Suspect hospitalized in deputy-involved identified, expected to - KUSI News - San Diego, CA

Suspect hospitalized in deputy-involved identified, expected to live

Posted: Updated:

EL CAJON (KUSI) — A man who was hospitalized in a deputy-involved shooting Friday night underwent successful surgery and is expect to live, San Diego County Sheriff's Department announced Saturday.

On September 8, 2017 at about 6:40 p.m., deputies from the Sheriff's Santee Station responded to a report of a male threatening to commit suicide.

31-year-old Robert Westbrook, a transient white male, was shot by a sheriff's deputy after exiting his vehicle with what appeared to be a handgun and engaging in a confrontation with the deputy.

The facts surrounding the confrontation are currently under investigation by the Sheriff's Homicide Detail.

The investigation has revealed the suspect was in possession of a realistic replica of a semiautomatic pistol, which apparently fires BB's, pellets, or similar spherical plastic pellet projectiles.

According to witness statements obtained by the sheriff's department, Westbrook stated the intent to have a law enforcement officer shoot him.

All northbound lanes of the SR-125 were closed for several hours Friday while the shooting was investigated.

According to sheriff's, the shooting happened around 7 p.m. on the SR-125 near Navajo Rd. and Grossmont College Dr. 

The suspect was treated at the scene by deputies before medics transported him to a local hospital, where he underwent successful surgery to repair multiple gunshot wounds. He is expected to survive.

Westbrook was charged with Assault with a Deadly Weapon and his bail was set at $50,000. The involved deputy was not injured. The deputy's name will be released in the next week.

Powered by Frankly

KUSI News

4575 Viewridge Ave. San Diego, CA 92123
Newsroom: 858-571-NEWS (6397)
Turko Files: 858-571-FILE (3453)
Business offices: 858-571-5151

Powered by WorldNow
All content © Copyright 2000 - 2017 KUSI. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.